Effect Chromosome Odds Ratio Estimate Lower CL* Upper CL
TFF1  Loss vs. Normal 21q22.3 3.019 1.514 6.02
TFF1 Gain vs. Normal   0.08 0.024 0.268
PRKDC Loss vs. Normal 8q11 0.276 0.11 0.692
PRKDC Gain vs. Normal   5.449 2.09 14.206
MYC Loss vs. Normal 8q24.12 0.221 0.097 0.503
MYC Gain vs. Normal   2.218 1.136 4.332
LTA Loss vs. Normal 6p21.3 2.156 1.172 3.965
LTA Gain vs. Normal   0.266 0.108 0.655
IL2 Loss vs. Normal 4q26 3.697 1.774 7.705
IL2 Gain vs. Normal   0.149 0.055 0.407
FGFR1 Loss vs. Normal 8p21 0.275 0.126 0.598
FGFR1 Gain vs. Normal   5.555 1.689 18.267
CTNNB1 Loss vs. Normal 3p22 2.682 1.394 5.162
CTNNB1 Gain vs. Normal   0.323 0.147 0.71
CDKN2A Loss vs. Normal 9p21 1.845 1.013 3.362
CDKN2A Gain vs. Normal   0.14 0.056 0.35
*CL: Confidence Limit
Table 1: Genes with corresponding loss and gain that predict tumor and non-tumor.